JAKAVI 10MG TABLET 10'S

JAKAVI 10MG TABLET 10'S should be cautiously taken if you have any kidney problems. Dose adjustments are necessary for patients with kidney diseases. Inform your doctor if you are on dialysis and have any kidney disorders.

Inform your physician if you have active tuberculosis or a past medical history of tuberculosis before starting the treatment with JAKAVI 10MG TABLET 10'S.

Grapefruit or grapefruit juice should be avoided while taking JAKAVI 10MG TABLET 10'S. Unless your doctor suggests special diets, you can follow the normal diet.

The medicine can suppress your immune system and increase your chances of getting infections. Take precautions to prevent illness and injury.

If you overdosed or took two doses of JAKAVI 10MG TABLET 10'S unknowingly, immediately inform your healthcare professional and seek medical advice.

Inform your doctor about all the medicines, supplements, or herbal products you are taking, as JAKAVI 10MG TABLET 10'S may interact with them. Your doctor will advise you accordingly.

You should continue taking this tablet until your doctor says, as it is a long-term treatment. Do not stop or reduce the dose without consulting your physician. Inform your physician if you get any infection or symptoms of bleeding. This medicine may make you prone to bleeding, bruising, or infections, so take precautions. Your doctor will perform regular lab tests to monitor the effects. Inform your doctor if you are a smoker.

The active ingredient in JAKAVI 10MG TABLET 10'S is RUXOLITINIB.

JAKAVI 10MG TABLET 10'S is used to treat certain types of blood disorders, including myelofibrosis and polycythemia vera, which are sometimes associated with or considered a type of blood cancer.

JAKAVI 10MG TABLET 10'S contains Ruxolitinib, which is a Janus kinase (JAK) inhibitor. It works by blocking the activity of certain enzymes called JAKs, which are involved in the body's immune response and blood cell production. In conditions like myelofibrosis and polycythemia vera, JAK signaling is overactive, and blocking it helps control symptoms and reduce spleen size.

Jakavi 10MG Tablet 10's contains Ruxolitinib 10 MG.

Jakavi 10MG Tablet 10's is listed at Rs. 37327.88 on Medkart. Prices can change — check the product page for the current price and pack size.

The dose of Jakavi 10MG Tablet 10's depends on your condition, age, weight and other medicines you take, so it must be decided by your doctor. Follow the dose and duration on your prescription and do not change it on your own.

A generic medicine is one with the same active composition as the branded product — for Jakavi 10MG Tablet 10's that is Ruxolitinib 10 MG. Medkart lists generic options by composition so you can compare. Ask your doctor or pharmacist before switching from Jakavi 10MG Tablet 10's.

Yes. Jakavi 10MG Tablet 10's requires a valid doctor's prescription.

Jakavi 10MG Tablet 10's is manufactured by Novartis India Limited.

Jakavi 10MG Tablet 10's is supplied as a tablet and is taken by the oral route.

Whether Jakavi 10MG Tablet 10's can be taken daily, and for how long, depends on your condition and must be decided by your doctor. Do not start, extend or repeat a course of Jakavi 10MG Tablet 10's on your own.

The timing of Jakavi 10MG Tablet 10's depends on the dose your doctor prescribes and on the other medicines you take. Follow the timing on your prescription or ask your pharmacist.

No. Jakavi 10MG Tablet 10's is a prescription medicine and should only be taken on a doctor's advice.

Store Jakavi 10MG Tablet 10's in its original pack, below 25°C unless the pack states otherwise, away from direct sunlight and moisture, and out of the reach of children. Do not use it after the expiry date on the pack.